EU begins discussions with Japan over MRA (mutual recognition agreement):
This article was originally published in Clinica
The medical devices units within the European Commission is about to start discussions with Japan concerning the drafting of a joint implementation plan for a mutual recognition agreement (MRA) between the two markets. Talks will be led by the EC's Directorate General Trade and will cover a variety of industrial sectors. They will be held via video conference between April 12-14. The devices unit has prepared well for this opportunity, but is understood to be open to suggestions from the Japanese. The intention is for timeframes to be agreed during the talks, as well as dates for future bilateral meetings.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.